Effects of midazolam and propofol on EEG detection of epileptiform activity in patients with altered consciousness.

Clin NeurophysiolMay 23, 2026 (epub)

Milène Guinchard, Andrea O Rossetti, Kaspar Schindler et al.

✦ AI-curated · Sources linked

In 30 seconds

This multicenter randomized controlled trial assessed the effects of midazolam and propofol on EEG detection of epileptiform activity in 364 adult patients with altered consciousness. The study found no significant difference in the detection of epileptiform activity between patients who received sedation and those who did not, despite sedation being more common in patients with structural brain injuries and lower consciousness scores.

Key findings

  • 67.6% of patients received sedative medication during the study.
  • Epileptiform discharges were more frequent in continuous EEG compared to routine EEG.
  • Sedation was not independently associated with EEG epileptiform activity.

Why it matters

Understanding the impact of sedative agents on EEG readings is crucial for accurate diagnosis and management of patients with altered consciousness. This study suggests that sedation may not significantly hinder the detection of epileptiform activity.

Source

Published in Clin Neurophysiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.